371 related articles for article (PubMed ID: 9428349)
1. Proteases and their inhibitors in human brain tumours: a review.
Rooprai HK; McCormick D
Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
[TBL] [Abstract][Full Text] [Related]
2. Proteases in brain tumour progression.
Levicar N; Nuttall RK; Lah TT
Acta Neurochir (Wien); 2003 Sep; 145(9):825-38. PubMed ID: 14505115
[TBL] [Abstract][Full Text] [Related]
3. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
Takagi M
Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
[TBL] [Abstract][Full Text] [Related]
4. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
5. Pericellular proteases in angiogenesis and vasculogenesis.
van Hinsbergh VW; Engelse MA; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
[TBL] [Abstract][Full Text] [Related]
6. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
Persky B; Ostrowski LE; Pagast P; Ahsan A; Schultz RM
Cancer Res; 1986 Aug; 46(8):4129-34. PubMed ID: 3524801
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
9. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
[TBL] [Abstract][Full Text] [Related]
10. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in tumour invasion and metastasis.
Curran S; Murray GI
J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
13. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
14. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases.
Campbell EJ; Cury JD; Shapiro SD; Goldberg GI; Welgus HG
J Immunol; 1991 Feb; 146(4):1286-93. PubMed ID: 1991967
[TBL] [Abstract][Full Text] [Related]
15. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
Zhang D; Samani AA; Brodt P
Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles for proteinases in cancer.
Noël A; Gilles C; Bajou K; Devy L; Kebers F; Lewalle JM; Maquoi E; Munaut C; Remacle A; Foidart JM
Invasion Metastasis; 1997; 17(5):221-39. PubMed ID: 9876217
[TBL] [Abstract][Full Text] [Related]
18. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
19. Viral proteinases--possible targets of antiviral drugs.
Maliar T; Baláz S; Tandlich R; Sturdík E
Acta Virol; 2002; 46(3):131-40. PubMed ID: 12580374
[TBL] [Abstract][Full Text] [Related]
20. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
Fröhlich E
Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
